India must build export-oriented medical devices industry, says pharma secretaryby Asia Today Team August 8, 2026 0 New Delhi: India should transfer past import substitution strategy within the medical gadgets sector and construct an export-oriented business that ...
Gland Pharma gets USFDA nod for generic sugammadex injectionby Asia Today Team July 29, 2026 0 New Delhi: Gland Pharma Ltd on Wednesday stated it has acquired approval from the US well being regulator for its ...
Alembic Pharma partner NATCO gets USFDA tentative nod for generic Olaparib tablets; US market size at USD 1.4 bnby Asia Today Team July 19, 2026 0 New Delhi: Alembic Prescription drugs stated its accomplice NATCO Pharma has obtained tentative approval from the USA Meals and Drug ...
Natco Pharma to invest Rs 2,500 crore in South Africa expansionby Asia Today Team July 8, 2026 0 New Delhi: Natco Pharma on Wednesday introduced investments of almost Rs 2,500 crore in South Africa, together with infusing Rs ...
Strides Pharma sells majority stake in arm Pivot Path for Rs 100 croreby Asia Today Team June 28, 2026 0 New Delhi, Strides Pharma Science Ltd on Saturday introduced divestment of majority stake in its wholly-owned arm Pivot Path for ...
The Geopolitics of India’s Pharma Power – The Diplomatby Asia Today Team June 29, 2026 0 When the USA’ Trump administration unveiled 100% tariffs on branded prescribed drugs in April 2026, India’s drugmakers breathed a sigh ...
India willing to open its market to high-quality, innovative pharma products, says commerce ministerby Asia Today Team June 9, 2026 0 New Delhi: India is prepared to open its market to high-quality and modern merchandise from the worldwide pharma sector in ...
Pharma exports to US seen muted this yearby Asia Today Team June 4, 2026 0 New Delhi: India's pharmaceutical exports to the US are more likely to stay subdued this 12 months, weighed down by ...
Mankind Pharma profit jumps 30% on chronic therapy demand in Q4by Asia Today Team May 20, 2026 0 New Delhi: Mankind Pharma on Tuesday reported a 30% year-on-year rise in fourth-quarter revenue, pushed by robust demand for persistent ...
A Game-Changer for India’s Pharma Sectorby Asia Today Team April 11, 2026 0 Mumbai: Solar Pharmaceutical Industries has determined to proceed with a binding supply of $12 billion for Organon & Co, taking ...